Ismaiel, A.; Oliveira-Grilo, G.; Leucuta, D.-C.; Al Srouji, N.; Ismaiel, M.; Popa, S.-L.
Leptin Unveiled: A Potential Biomarker for Acute Coronary Syndrome with Implications for Tailored Therapy in Patients with Type 2 Diabetes—Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2025, 26, 3925.
https://doi.org/10.3390/ijms26093925
AMA Style
Ismaiel A, Oliveira-Grilo G, Leucuta D-C, Al Srouji N, Ismaiel M, Popa S-L.
Leptin Unveiled: A Potential Biomarker for Acute Coronary Syndrome with Implications for Tailored Therapy in Patients with Type 2 Diabetes—Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2025; 26(9):3925.
https://doi.org/10.3390/ijms26093925
Chicago/Turabian Style
Ismaiel, Abdulrahman, Gaëlle Oliveira-Grilo, Daniel-Corneliu Leucuta, Nahlah Al Srouji, Mohamed Ismaiel, and Stefan-Lucian Popa.
2025. "Leptin Unveiled: A Potential Biomarker for Acute Coronary Syndrome with Implications for Tailored Therapy in Patients with Type 2 Diabetes—Systematic Review and Meta-Analysis" International Journal of Molecular Sciences 26, no. 9: 3925.
https://doi.org/10.3390/ijms26093925
APA Style
Ismaiel, A., Oliveira-Grilo, G., Leucuta, D.-C., Al Srouji, N., Ismaiel, M., & Popa, S.-L.
(2025). Leptin Unveiled: A Potential Biomarker for Acute Coronary Syndrome with Implications for Tailored Therapy in Patients with Type 2 Diabetes—Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 26(9), 3925.
https://doi.org/10.3390/ijms26093925